GHK-Cu Copper Peptide Extends Lifespan by Boosting Mitochondria and Stress Defenses
A natural copper-bound tripeptide extends worm lifespan, improves physical function, and activates two major longevity pathways simultaneously.
Summary
Researchers tested GHK-Cu — a copper complex of the naturally occurring tripeptide Glycine-Histidine-Lysine found in human plasma — in C. elegans worms and found it significantly extended lifespan while improving multiple markers of health. The compound preserved mitochondrial structure and energy production, prevented age-related fragmentation of mitochondrial networks, and activated two well-established longevity pathways: DAF-16 (FOXO) and SKN-1 (Nrf2). Treated worms showed better movement, feeding, and stress resistance, plus reduced accumulation of aging pigment lipofuscin. This is the first study to mechanistically link GHK-Cu to coordinated mitochondrial and transcriptional anti-aging effects.
Detailed Summary
Oxidative stress and mitochondrial decline are central drivers of biological aging. Finding compounds that address both simultaneously — while also activating the body's own longevity gene programs — is a key goal in geroprotective research. GHK-Cu, a copper-chelated form of a tripeptide naturally present in human blood, has long been studied for skin repair and wound healing, but its deeper anti-aging biology has remained poorly characterized until now.
This study used Caenorhabditis elegans, the workhorse model organism of aging research, to rigorously test GHK-Cu across lifespan and healthspan endpoints. Worms treated with GHK-Cu lived significantly longer and maintained better physical function — including improved locomotion, pharyngeal pumping rate, and defecation rhythm — compared to controls. They also accumulated less lipofuscin, a hallmark pigment of cellular aging, and stored fewer lipids.
At the cellular level, GHK-Cu preserved mitochondrial membrane potential and promoted mitochondrial fusion over fragmentation by modulating expression of the fission gene drp-1 and fusion gene fzo-1. This structural preservation correlated with increased ATP production, suggesting genuine improvement in bioenergetic capacity rather than just stress buffering.
On the transcriptional side, GHK-Cu activated both the DAF-16/FOXO and SKN-1/Nrf2 pathways — two of the most conserved and well-validated longevity-promoting signaling cascades — and upregulated downstream targets including antioxidant enzymes sod-3, gst-4, gcs-1, lys-7, and lys-8. The dual activation of both pathways together distinguishes GHK-Cu from many single-target compounds.
While findings are limited to a model organism, the mechanistic clarity and multi-pathway engagement position GHK-Cu as a credible candidate for further anti-aging investigation in mammals and eventually humans.
Key Findings
- GHK-Cu significantly extended C. elegans lifespan and improved motility, feeding rate, and stress resistance.
- The compound preserved mitochondrial membrane potential and shifted dynamics toward fusion, boosting ATP output.
- GHK-Cu activated both DAF-16/FOXO and SKN-1/Nrf2 longevity pathways simultaneously.
- Downstream antioxidant genes sod-3, gst-4, gcs-1, lys-7, and lys-8 were upregulated.
- Lipofuscin and lipid accumulation — hallmarks of aging — were reduced in treated worms.
Methodology
The study used Caenorhabditis elegans as an in vivo aging model, assessing lifespan curves, healthspan phenotypes (motility, pumping, defecation), and cellular markers (lipofuscin, lipid staining, mitochondrial morphology, membrane potential, ATP levels). Gene expression analysis and pathway reporter assays were used to confirm DAF-16 and SKN-1 activation and downstream target upregulation.
Study Limitations
All experiments were conducted in C. elegans, a nematode with limited physiological similarity to humans; findings require validation in mammalian models. Optimal dosing, bioavailability, and safety profiles in higher organisms are unknown. The study did not establish whether the copper ion or the GHK peptide alone drives the observed effects.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.